The global benign prostatic hyperplasia (BPH) prostate treatment market is set for consistent growth, with its valuation ...

Frequent urination or a weak urine system might be due to an underlying serious condition like Benign Prostatic Hyperplasia.

Benign Prostatic Hyperplasia (BPH) is a common condition that affects many men as they age, causing the prostate to enlarge ...

Adjunct treatment with anastrozole in children with congenital adrenal hyperplasia (CAH) delays the rate of bone maturation and increases the predicted adult height over 6 years, with no significant ...

Pharmacy Plus, a leading pharmaceutical company, has launched Duostam, an advanced treatment for Benign Prostatic Hyperplasia ...

Britain's King Charles has been recently diagnosed with cancer while undergoing treatment for an enlarged prostate or benign prostatic hyperplasia. While the type and stage of malignancy still remains ...

Prostatic artery embolization or PAE is a minimally invasive treatment that helps improve lower urinary tract symptoms caused ...

The volume of distribution of alfuzosin is 2.5 L/kg, and 90% of each dose is protein bound. Because the volume of distribution of alfuzosin is lower in some elderly patients, the initial dose in ...

Urological and fertility issues are common and treatable. Men need to prioritise their health by making lifestyle changes, ...

Pharmacy Plus has set a new standard in prostate health care with the launch of Duostam, an innovative treatment for Benign Prostatic Hyperplasia (BPH), ...